Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets

New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays MarketsBy Global Information, Inc. Published: Wednesday, May. 30, 2012 - 10:04 am FARMINGTON, Conn., May 30, 2012 -- /PRNewswire-iReach/ -- Global Information Inc is pleased to announce the immediate availability of two new market research reports from Greystone Research Associates examining the markets for Transmucosal Drug Delivery and Systemic Nasal Sprays.Oral Transmucosal Drug Delivery Market Greystone Research Associates' new market study "Oral Transmucosal Drug Delivery: Products, Players, Markets and Forecasts" is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The report offers a detailed understanding of the products, markets and commercial opportunities for drug delivery films, sprays, lozenges, wafers and orally dissolvable tablets that are designed to be administered into the oral cavity and be absorbed systematically via the oral mucosa.The permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route.The report analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market, with market data and forecasts to 2016. It also covers oral transmucosal drug products and pipeline product candidates.Systemic Nasal Sprays Market Nasal delivery offers the potential for faster onset of action and less frequent dosing relative to oral drugs. As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies for chronic conditions such as diabetes, arthritis, and hormone replacement therapy, drug developers are showing increased interest in routes of administration that are patient-friendly and cost-effective. Intranasal administration is well positioned to take advantage of these trends and evolve into a significant role in the future of pharmaceutical development and commercialization.Intranasal delivery will grow at the expense of the predominant drug delivery methods (oral and parenteral), which cannot be readily optimized for the delivery and dosing of a significant portion of biologically derived drug substances.The report: "Systemic Nasal Sprays: Products, Players, Markets and Forecasts" analyzes nasal spray product strategies, technologies and patch development issues and provides assessments of intranasal systemic drug products, key design factors and strategic device factors, including market data and forecasts to 2016.An Executive Summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/grey242924-systemic-nasal-sprays-products-players-markets.htmlAbout Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp News distributed by PR Newswire iReach: https://ireach.prnewswire.comSOURCE Global Information, Inc.